1. The Traditional Indica/Sativa Classification — Where It Goes Wrong
For over 200 years, the cannabis community has divided strains into two groups: Indica (short, broad leaves, “body high”) and Sativa (tall, narrow leaves, “head high”). This classification originated from botanist Jean-Baptiste Lamarck (1785), based on plant morphology observed in India.
However, modern science has proven that this classification CANNOT predict pharmacological effects.
1.1. Scientific evidence debunking the myth
Nature Plants (2021) — Watts et al. re-analysed 297 drug-type cannabis samples from the Netherlands (137 of them genotyped). Result: Sativa- and Indica-labelled samples were genetically indistinct on a genome-wide scale; the labels tracked only a few terpenes (e.g. myrcene for “Indica”) linked to terpene synthase genes.
PLOS ONE (2022) — Smith et al. analysed 89,923 commercial flower samples from six US states: Indica, Sativa and Hybrid samples were highly intermingled, and labels did not consistently align with the observed chemical diversity.
2. Terpenes — The True Determinant of Effects
Terpenes are natural aromatic compounds that determine the smell, flavor, and pharmacological effects of each cannabis strain.
2.1. Key terpenes and their effects
| Terpene | Characteristic Scent | Pharmacological Effects | Representative Strains |
|---|---|---|---|
| Myrcene | Mango, hops | Sedative, muscle relaxant, anti-inflammatory, enhances THC absorption through BBB | OG Kush, Granddaddy Purple |
| Limonene | Lemon, orange | Antidepressant, anxiolytic, antibacterial | Super Lemon Haze, Durban Poison |
| Linalool | Lavender | Anticonvulsant, sedative, neuropathic pain relief | Lavender, Amnesia Haze |
| β-Caryophyllene | Black pepper | Strong anti-inflammatory (CB2 agonist), analgesic | GSC, Original Glue |
| α-Pinene | Pine, eucalyptus | Bronchodilator, anti-inflammatory, improves focus | Jack Herer, Blue Dream |
| Terpinolene | Wood, herbal | Mild sedative, antioxidant | Jack Herer, Dutch Treat |
| Humulene | Hops | Anti-inflammatory, appetite suppressant | White Widow, Headband |
2.2. The Entourage Effect
Research by Russo (2011): terpenes interact synergistically with cannabinoids:
- Myrcene + THC → sedative effect increased 2-3x
- Limonene + CBD → superior anxiolytic efficacy
- β-Caryophyllene + CBD → anti-inflammatory stronger than NSAIDs
- α-Pinene + THC → reduces THC-induced short-term memory impairment
3. Strain Selection Guide for 7 Medical Symptoms
Reference information based on scientific research. Always consult a physician before using medical cannabis.
| Symptom | Priority Terpenes | Cannabinoids | Suggested Ratio | Reference Strains |
|---|---|---|---|---|
| Chronic Pain | β-Caryophyllene, Myrcene, Linalool | THC + CBD | THC:CBD = 1:1 | Harlequin, ACDC, Cannatonic |
| Anxiety | Limonene, Linalool, β-Caryophyllene | High CBD, low THC | CBD:THC ≥ 8:1 | Charlotte’s Web, Ringo’s Gift |
| Insomnia | Myrcene, Linalool, Terpinolene | THC + CBN | Moderate THC + CBN | Granddaddy Purple, Northern Lights |
| Epilepsy | Linalool, Myrcene | Very high CBD | CBD:THC ≥ 20:1 | Charlotte’s Web, ACDC |
| Depression | Limonene, α-Pinene, Terpinolene | Low-moderate THC + CBD | THC:CBD = 1:2 | Jack Herer, Harlequin |
| Nausea | Limonene, β-Caryophyllene, Myrcene | THC + THCV | THC dominant | Durban Poison, Super Lemon Haze |
| PTSD | Linalool, Limonene, β-Caryophyllene | Moderate THC + CBD | THC:CBD = 1:1 → 2:1 | Blue Dream, OG Kush |
4. 5-Step Medical Strain Selection Process
Step 1: Identify primary symptoms (1-3 symptoms in priority order)
Step 2: Look up matching terpene profiles (see table above)
Step 3: Request a COA (Certificate of Analysis) — cannabinoid profile, terpenes, heavy metals, pesticides
Step 4: Start Low, Go Slow — begin with 2.5mg THC, increase by 2.5mg every 3-5 days
Step 5: Evaluate after 2-4 weeks, adjust dosage or switch strains
5. When Are Indica/Sativa Labels Still Useful?
| Characteristic | Indica-dominant | Sativa-dominant |
|---|---|---|
| Height | 60-120cm | 150-300cm+ |
| Flowering Time | 7-9 weeks | 10-14 weeks |
| Bud Structure | Dense, compact | Airy, elongated |
| Suited For | Indoor, limited space | Outdoor, tropical |
Conclusion: Indica/Sativa → use when GROWING (morphology). Terpenes/Cannabinoids → use when CONSUMING (effects).
6. Summary Table: Old vs New
| Old Way (Indica/Sativa) | New Way (Chemotype) | |
|---|---|---|
| Basis | Plant morphology | Chemical composition |
| Effect Prediction | ~40% accurate | Highly accurate (with COA) |
| Personalization | 2 choices | Hundreds of profiles |
| Evidence | Anecdotal | Peer-reviewed |
References
- Watts S. et al. (2021). Cannabis labelling is associated with genetic variation in terpene synthase genes. Nature Plants, 7(10), 1330–1334. doi:10.1038/s41477-021-01003-y
- Smith C.J., Vergara D., Keegan B., Jikomes N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498. doi:10.1371/journal.pone.0267498
- Russo E.B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364. doi:10.1111/j.1476-5381.2011.01238.x
- McPartland J.M. (2018). Cannabis and Cannabinoid Research, 3(1), 203–212.
- Mudge E.M. et al. (2018). Chemometric Analysis of Cannabinoids: Chemotaxonomy and Domestication Syndrome. Scientific Reports, 8, 13090. doi:10.1038/s41598-018-31120-2
- Fischedick J.T. (2017). Cannabis and Cannabinoid Research, 2(1), 34–47.
- Gallily R. et al. (2015). Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol. Pharmacology & Pharmacy, 6(2), 75–85. doi:10.4236/pp.2015.62010
- Devinsky O. et al. (2017). NEJM, 376, 2011–2020.
- Bonn-Miller M.O. et al. (2017). JAMA, 318(17), 1708–1709.
- Vergara D. et al. (2021). Frontiers in Plant Science, 12, 668315.
- Baron E.P. (2018). Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain. Headache, 58(7), 1139–1186. doi:10.1111/head.13345
- Ministry of Public Health (2025). Notification of the Ministry of Public Health Re: Controlled Herbs (Cannabis), B.E. 2568.
DISCLAIMER: Educational content only. Not medical advice. Cannabis in Thailand regulated under Notification of the Ministry of Public Health Re: Controlled Herbs (Cannabis), B.E. 2568 & Ministerial Regulation B.E. 2569. PT33 prescription required. Recreational use prohibited.